ArticleTherapeutic advances in urology

Assessing the effectiveness and safety of lenvatinib and everolimus in advanced renal cell carcinoma: insights from the RELIEVE study's analysis of heavily pretreated patients.

Sebastiano Buti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.